ReviewArchives of microbiology2026
Genetically engineered lipases: advances in expression and upscaling for industrial applications.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lipases are versatile enzymes with widespread industrial applications, including detergents, food processing, pharmaceuticals, biofuels, and environmental cleanup. Their ability to catalyze both hydrolytic and synthetic reactions under diverse conditions underpins their biotechnological significance. Native lipases, however, exhibit limitations such as low stability, narrow substrate spectrum, and low production yields, which limit their large-scale application. Emerging developments in genetic and protein engineering have enabled accurate modulation of enzyme properties and expression systems, offering potential solutions to overcome these challenges. This review presents an integrated view of existing strategies for designing high-performance lipases for industrial applications. It summarizes advancements from metagenomic discovery and gene optimization to expression optimization through codon improvement, promoter adjustment, signal peptide design, and chaperone-mediated folding. Protein engineering strategies, including rational design, directed evolution, and domain recombination; are addressed to enhance catalytic activity, selectivity, and thermostability. Concomitantly, breakthroughs in fermentation optimization, host metabolism engineering, and enzyme immobilization have enhanced the scalability and operational robustness of lipase manufacturing. Novel omics-driven and systems biology platforms now facilitate the rational design of microbial hosts optimized for efficient enzyme biosynthesis. Collectively, these advances outline a coherent blueprint for engineering lipases into strong, industrially applicable biocatalysts.
Indexed as
Identifiers
41863618What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.